Losartan suppresses the kainate-induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy
Experimental and clinical studies have demonstrated that components of renin-angiotensin system are elevated in the hippocampus in epileptogenic conditions. In the present work, we explored the changes in the expression of angiotensin II receptor, type 1 (AT1 receptor) in limbic structures, as well...
Gespeichert in:
| Veröffentlicht in: | Life sciences (1973) 2018-01, Vol.193, p.40-46 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 46 |
|---|---|
| container_issue | |
| container_start_page | 40 |
| container_title | Life sciences (1973) |
| container_volume | 193 |
| creator | Atanasova, Dimitrinka Tchekalarova, Jana Ivanova, Natasha Nenchovska, Zlatina Pavlova, Ekaterina Atanassova, Nina Lazarov, Nikolai |
| description | Experimental and clinical studies have demonstrated that components of renin-angiotensin system are elevated in the hippocampus in epileptogenic conditions. In the present work, we explored the changes in the expression of angiotensin II receptor, type 1 (AT1 receptor) in limbic structures, as well as the effect of the AT1 receptor antagonist losartan in a model of comorbid hypertension and epilepsy.
The expression of AT1 receptors was compared between spontaneously hypertensive rats (SHRs) and Wistar rats by using immunohistochemistry in the kainate (KA) model of temporal lobe epilepsy (TLE). The effect of losartan was studied on AT1 receptor expression in epileptic rats that were treated for a period of 4weeks after status epilepticus.
The naive and epileptic SHRs were characterized by stronger protein expression of AT1 receptor than normotensive Wistar rats in the CA1, CA3a, CA3b, CA3c field and the hilus of the dentate gyrus of the dorsal hippocampus but fewer cells were immunostained in the piriform cortex. Increased AT1 immunostaining was observed in the basolateral amygdala of epileptic SHRs but not of epileptic Wistar rats. Losartan exerted stronger and structure-dependent suppression of AT1 receptor expression in SHRs compared to Wistar rats.
Our results confirm the important role of AT1 receptor in epilepsy and suggest that the AT1receptor antagonists could be used as a therapeutic strategy for treatment of comorbid hypertension and epilepsy. |
| doi_str_mv | 10.1016/j.lfs.2017.12.006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_elsev</sourceid><recordid>TN_cdi_proquest_miscellaneous_2067266822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320517306331</els_id><sourcerecordid>2067266822</sourcerecordid><originalsourceid>FETCH-LOGICAL-e188t-dc052000c04cc5d56c5e67f1d2cdca1610d0a93ac11c2b658e6e48745487abae3</originalsourceid><addsrcrecordid>eNotkE1OwzAQhS0EEqVwAHZeskkYO7GTilVV8SdVYlPWlmtPqEtqhzhB9ARcG7dlMzPSvPc08xFyyyBnwOT9Nm-bmHNgVc54DiDPyITV1SwDWbBzMgHgZVZwEJfkKsYtAAhRFRPyuwxR94P2NI5d12OMGOmwQfqpndcDZs7b0aClZqP9R9qFhqbBhQF9dJ7OV4z2aLAbQk_x55jggqdppekuWGwPDhN2oV87Szf7DvujNWm0txQ712IX99fkotFtxJv_PiXvT4-rxUu2fHt-XcyXGbK6HjJrQPB0vIHSGGGFNAJl1TDLjTWaSQYW9KzQhjHD11LUKLGsq1Kkotcaiym5O-V2ffgaMQ5q56LBttUewxgVB1lxKWvOk_ThJMV0z7fDXkXj0CcYLn08KBucYqAO-NVWJfzqgF8xrhL-4g8PJn1I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2067266822</pqid></control><display><type>article</type><title>Losartan suppresses the kainate-induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy</title><source>Elsevier ScienceDirect Journals</source><creator>Atanasova, Dimitrinka ; Tchekalarova, Jana ; Ivanova, Natasha ; Nenchovska, Zlatina ; Pavlova, Ekaterina ; Atanassova, Nina ; Lazarov, Nikolai</creator><creatorcontrib>Atanasova, Dimitrinka ; Tchekalarova, Jana ; Ivanova, Natasha ; Nenchovska, Zlatina ; Pavlova, Ekaterina ; Atanassova, Nina ; Lazarov, Nikolai</creatorcontrib><description>Experimental and clinical studies have demonstrated that components of renin-angiotensin system are elevated in the hippocampus in epileptogenic conditions. In the present work, we explored the changes in the expression of angiotensin II receptor, type 1 (AT1 receptor) in limbic structures, as well as the effect of the AT1 receptor antagonist losartan in a model of comorbid hypertension and epilepsy.
The expression of AT1 receptors was compared between spontaneously hypertensive rats (SHRs) and Wistar rats by using immunohistochemistry in the kainate (KA) model of temporal lobe epilepsy (TLE). The effect of losartan was studied on AT1 receptor expression in epileptic rats that were treated for a period of 4weeks after status epilepticus.
The naive and epileptic SHRs were characterized by stronger protein expression of AT1 receptor than normotensive Wistar rats in the CA1, CA3a, CA3b, CA3c field and the hilus of the dentate gyrus of the dorsal hippocampus but fewer cells were immunostained in the piriform cortex. Increased AT1 immunostaining was observed in the basolateral amygdala of epileptic SHRs but not of epileptic Wistar rats. Losartan exerted stronger and structure-dependent suppression of AT1 receptor expression in SHRs compared to Wistar rats.
Our results confirm the important role of AT1 receptor in epilepsy and suggest that the AT1receptor antagonists could be used as a therapeutic strategy for treatment of comorbid hypertension and epilepsy.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2017.12.006</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>amygdala ; angiotensin II ; animal disease models ; antagonists ; AT1 receptors ; clinical trials ; cortex ; epilepsy ; hippocampus ; hypertension ; immunohistochemistry ; Kainate ; Losartan ; protein synthesis ; rats ; receptors ; renin-angiotensin system ; Spontaneously hypertensive rat ; Wistar rat</subject><ispartof>Life sciences (1973), 2018-01, Vol.193, p.40-46</ispartof><rights>2017 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-1640-5099</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0024320517306331$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Atanasova, Dimitrinka</creatorcontrib><creatorcontrib>Tchekalarova, Jana</creatorcontrib><creatorcontrib>Ivanova, Natasha</creatorcontrib><creatorcontrib>Nenchovska, Zlatina</creatorcontrib><creatorcontrib>Pavlova, Ekaterina</creatorcontrib><creatorcontrib>Atanassova, Nina</creatorcontrib><creatorcontrib>Lazarov, Nikolai</creatorcontrib><title>Losartan suppresses the kainate-induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy</title><title>Life sciences (1973)</title><description>Experimental and clinical studies have demonstrated that components of renin-angiotensin system are elevated in the hippocampus in epileptogenic conditions. In the present work, we explored the changes in the expression of angiotensin II receptor, type 1 (AT1 receptor) in limbic structures, as well as the effect of the AT1 receptor antagonist losartan in a model of comorbid hypertension and epilepsy.
The expression of AT1 receptors was compared between spontaneously hypertensive rats (SHRs) and Wistar rats by using immunohistochemistry in the kainate (KA) model of temporal lobe epilepsy (TLE). The effect of losartan was studied on AT1 receptor expression in epileptic rats that were treated for a period of 4weeks after status epilepticus.
The naive and epileptic SHRs were characterized by stronger protein expression of AT1 receptor than normotensive Wistar rats in the CA1, CA3a, CA3b, CA3c field and the hilus of the dentate gyrus of the dorsal hippocampus but fewer cells were immunostained in the piriform cortex. Increased AT1 immunostaining was observed in the basolateral amygdala of epileptic SHRs but not of epileptic Wistar rats. Losartan exerted stronger and structure-dependent suppression of AT1 receptor expression in SHRs compared to Wistar rats.
Our results confirm the important role of AT1 receptor in epilepsy and suggest that the AT1receptor antagonists could be used as a therapeutic strategy for treatment of comorbid hypertension and epilepsy.</description><subject>amygdala</subject><subject>angiotensin II</subject><subject>animal disease models</subject><subject>antagonists</subject><subject>AT1 receptors</subject><subject>clinical trials</subject><subject>cortex</subject><subject>epilepsy</subject><subject>hippocampus</subject><subject>hypertension</subject><subject>immunohistochemistry</subject><subject>Kainate</subject><subject>Losartan</subject><subject>protein synthesis</subject><subject>rats</subject><subject>receptors</subject><subject>renin-angiotensin system</subject><subject>Spontaneously hypertensive rat</subject><subject>Wistar rat</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNotkE1OwzAQhS0EEqVwAHZeskkYO7GTilVV8SdVYlPWlmtPqEtqhzhB9ARcG7dlMzPSvPc08xFyyyBnwOT9Nm-bmHNgVc54DiDPyITV1SwDWbBzMgHgZVZwEJfkKsYtAAhRFRPyuwxR94P2NI5d12OMGOmwQfqpndcDZs7b0aClZqP9R9qFhqbBhQF9dJ7OV4z2aLAbQk_x55jggqdppekuWGwPDhN2oV87Szf7DvujNWm0txQ712IX99fkotFtxJv_PiXvT4-rxUu2fHt-XcyXGbK6HjJrQPB0vIHSGGGFNAJl1TDLjTWaSQYW9KzQhjHD11LUKLGsq1Kkotcaiym5O-V2ffgaMQ5q56LBttUewxgVB1lxKWvOk_ThJMV0z7fDXkXj0CcYLn08KBucYqAO-NVWJfzqgF8xrhL-4g8PJn1I</recordid><startdate>20180115</startdate><enddate>20180115</enddate><creator>Atanasova, Dimitrinka</creator><creator>Tchekalarova, Jana</creator><creator>Ivanova, Natasha</creator><creator>Nenchovska, Zlatina</creator><creator>Pavlova, Ekaterina</creator><creator>Atanassova, Nina</creator><creator>Lazarov, Nikolai</creator><general>Elsevier Inc</general><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0003-1640-5099</orcidid></search><sort><creationdate>20180115</creationdate><title>Losartan suppresses the kainate-induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy</title><author>Atanasova, Dimitrinka ; Tchekalarova, Jana ; Ivanova, Natasha ; Nenchovska, Zlatina ; Pavlova, Ekaterina ; Atanassova, Nina ; Lazarov, Nikolai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e188t-dc052000c04cc5d56c5e67f1d2cdca1610d0a93ac11c2b658e6e48745487abae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>amygdala</topic><topic>angiotensin II</topic><topic>animal disease models</topic><topic>antagonists</topic><topic>AT1 receptors</topic><topic>clinical trials</topic><topic>cortex</topic><topic>epilepsy</topic><topic>hippocampus</topic><topic>hypertension</topic><topic>immunohistochemistry</topic><topic>Kainate</topic><topic>Losartan</topic><topic>protein synthesis</topic><topic>rats</topic><topic>receptors</topic><topic>renin-angiotensin system</topic><topic>Spontaneously hypertensive rat</topic><topic>Wistar rat</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Atanasova, Dimitrinka</creatorcontrib><creatorcontrib>Tchekalarova, Jana</creatorcontrib><creatorcontrib>Ivanova, Natasha</creatorcontrib><creatorcontrib>Nenchovska, Zlatina</creatorcontrib><creatorcontrib>Pavlova, Ekaterina</creatorcontrib><creatorcontrib>Atanassova, Nina</creatorcontrib><creatorcontrib>Lazarov, Nikolai</creatorcontrib><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Atanasova, Dimitrinka</au><au>Tchekalarova, Jana</au><au>Ivanova, Natasha</au><au>Nenchovska, Zlatina</au><au>Pavlova, Ekaterina</au><au>Atanassova, Nina</au><au>Lazarov, Nikolai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Losartan suppresses the kainate-induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy</atitle><jtitle>Life sciences (1973)</jtitle><date>2018-01-15</date><risdate>2018</risdate><volume>193</volume><spage>40</spage><epage>46</epage><pages>40-46</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Experimental and clinical studies have demonstrated that components of renin-angiotensin system are elevated in the hippocampus in epileptogenic conditions. In the present work, we explored the changes in the expression of angiotensin II receptor, type 1 (AT1 receptor) in limbic structures, as well as the effect of the AT1 receptor antagonist losartan in a model of comorbid hypertension and epilepsy.
The expression of AT1 receptors was compared between spontaneously hypertensive rats (SHRs) and Wistar rats by using immunohistochemistry in the kainate (KA) model of temporal lobe epilepsy (TLE). The effect of losartan was studied on AT1 receptor expression in epileptic rats that were treated for a period of 4weeks after status epilepticus.
The naive and epileptic SHRs were characterized by stronger protein expression of AT1 receptor than normotensive Wistar rats in the CA1, CA3a, CA3b, CA3c field and the hilus of the dentate gyrus of the dorsal hippocampus but fewer cells were immunostained in the piriform cortex. Increased AT1 immunostaining was observed in the basolateral amygdala of epileptic SHRs but not of epileptic Wistar rats. Losartan exerted stronger and structure-dependent suppression of AT1 receptor expression in SHRs compared to Wistar rats.
Our results confirm the important role of AT1 receptor in epilepsy and suggest that the AT1receptor antagonists could be used as a therapeutic strategy for treatment of comorbid hypertension and epilepsy.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.lfs.2017.12.006</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-1640-5099</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0024-3205 |
| ispartof | Life sciences (1973), 2018-01, Vol.193, p.40-46 |
| issn | 0024-3205 1879-0631 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2067266822 |
| source | Elsevier ScienceDirect Journals |
| subjects | amygdala angiotensin II animal disease models antagonists AT1 receptors clinical trials cortex epilepsy hippocampus hypertension immunohistochemistry Kainate Losartan protein synthesis rats receptors renin-angiotensin system Spontaneously hypertensive rat Wistar rat |
| title | Losartan suppresses the kainate-induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T04%3A45%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_elsev&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Losartan%20suppresses%20the%20kainate-induced%20changes%20of%20angiotensin%20AT1%20receptor%20expression%20in%20a%20model%20of%20comorbid%20hypertension%20and%20epilepsy&rft.jtitle=Life%20sciences%20(1973)&rft.au=Atanasova,%20Dimitrinka&rft.date=2018-01-15&rft.volume=193&rft.spage=40&rft.epage=46&rft.pages=40-46&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2017.12.006&rft_dat=%3Cproquest_elsev%3E2067266822%3C/proquest_elsev%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2067266822&rft_id=info:pmid/&rft_els_id=S0024320517306331&rfr_iscdi=true |